DR-TB and PMDT

Clinical Monitoring of DR-TB Patients

Describe Management of Drug-resistant TB.

Rapid Molecular Drug-resistance Testing

DR-TB Service Referral Linkages Scenario 5: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector ​​

DR-TB Service Referral Linkages Scenario 3: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector

DR-TB Services Referral Linkage Scenario 1: Patient Notified from the Private Sector

Understand the institutional requirements for establishing a Nodal Drug-Resistant Tuberculosis (DR-TB) Centre.

• Understand the eligibility criteria for initiating treatment with shorter oral bedaquiline-containing regimens for multidrug-resistant (MDR) and rifampicin-resistant (RR) tuberculosis (TB) patients.
• Recognize the DST based inclusion criteria and other criteria.

Understand conditions for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension using the algorithm.

Learn about Shorter oral Bedaquiline-containing MDR/RR-TB regimen